migraine. Migraine
Conditions
Interventions
Intervention 1: Intervention group: The first group received 500 mg of levetiracetam per day. Intervention 2: Intervention group: The second group received 500 mg/day sodium sulfate.
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 18 to 65 years old Migraine headache history for at least 6 months before study based on IHS criteria Moderate to severe headache for less than 6 days with Visual Analogue Scale Natural Signs and Natural Nerve Findings.
Exclusion criteria
Exclusion criteria: Patients with kidney failure, liver disease, heart disease, active stomach ulcer disease or diabetes or abnormal vital symptoms Allergy to valproate and Levetiracetam Pregnant or lactating women Cases of other types of headaches such as sinus headaches Taking nonsteroidal anti-inflammatory drugs within 24 hours or valproate over the past 2 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache severity. Timepoint: Before the start of the study, notes were taken every 30 days. Method of measurement: Based on VAS and doctor.;Number of headaches per month. Timepoint: Before the start of the study, notes were taken every 30 days. Method of measurement: MIDAS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadhosein Saffari
Shahre-kord University of Medical Sciences
Outcome results
None listed